Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. - Wikidata - awgldk - TriplyDB

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

http://www.wikidata.org/entity/Q35938554

about

Visual dysfunction in Parkinson's disease Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death Cognitive profile of LRRK2-related Parkinson's disease Mitochondrial dysfunction associated with glucocerebrosidase deficiency Neuropsychiatric characteristics of GBA-associated Parkinson disease.Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons.The neurobiological basis of cognitive impairment in Parkinson's disease.Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.Visual short-term memory deficits associated with GBA mutation and Parkinson's disease.Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease Significant study of population stratification, sensitivity analysis and trim and fill analyses on GBA mutation and Parkinson's disease.Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.Differential effects of severe vs mild GBA mutations on Parkinson disease.Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein.Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations Effect of GBA Mutations on Phenotype of Parkinson's Disease: A Study on Chinese Population and a Meta-Analysis.GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease.The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease.Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulation Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound Aβ.Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models.A molecular analysis of the GBA gene in Caucasian South Africans with Parkinson's disease.The association between ß-glucocerebrosidase mutations and parkinsonism Glucocerebrosidase mutations and the pathogenesis of Parkinson disease.

P2860

Q26740467-F102BAB0-708B-4AA4-982F-D93F774F36AC Q27300869-56953C0F-50D4-49B8-8FD9-1C72888DF3FD Q27333093-06EB4DF2-EE59-4360-B888-49270B369DB7 Q28115678-5003AB1B-AEDD-4F64-8E53-EFC9FB45FFCB Q30275630-6AF63FC7-BDA1-4BD4-B0B5-F7A506D1E9DC Q30367337-B719A72D-BEF6-4E3B-890E-25B3F27A2587 Q30409165-890DDF9C-D80C-44B2-A67E-31755ED23AA8 Q30544056-784C2377-E3B8-4C52-979A-B5ADF201114C Q30700188-D3160922-C197-46E1-BCD4-2594E309E6D1 Q31097119-0FB593A5-93C3-4285-AF85-CF5897616E1E Q33616462-4B30DA7F-CFD6-4F47-8EA5-45DF9D9FFF88 Q33724698-63F7D1E6-8ADA-4BA4-A55E-F0595D4334C7 Q33849233-044681A8-7556-48B2-AC69-99F0027CF39C Q33937498-961F1B18-A674-4829-BC3A-4AB94FFF3336 Q34562789-F8EA53B9-7442-4B26-8ABB-2E799C22E50E Q34994293-CED6B657-2DEF-4E05-890A-323010E72E92 Q35013928-59354DF0-D522-41B4-8FC4-4021A60D563E Q35045322-4E9E734A-5042-4AE4-8D63-F520FF81E7B2 Q35079812-05F53A62-FA44-4DC0-B915-5A52305089DB Q35153677-BB23DE24-39E2-402F-8C1D-3798F2C1A85D Q35568431-A9BAE9B7-1F29-4D44-8889-D491C2FBA9D0 Q35674483-C455CB2F-397E-454F-B887-65B54BEE1DE5 Q36041420-E21F52EA-1DBD-400A-82CA-3BF612362797 Q36066518-58472869-6547-41ED-86A0-D284FD12081D Q36072435-68F71888-89E5-4463-907D-3519DE8C7145 Q36123828-3E23D320-603D-4693-A677-55E4785A8F8B Q36124421-2FBFE9AA-E223-41A9-9D9F-030DA1A5026D Q36169215-8D12980E-4A93-42A8-8AA3-13FD18227629 Q36653957-13DD55D7-D1D4-466C-8F87-8B658A1F3AD2 Q36885946-25B8B74C-9CB7-4E78-A287-B43D94BC2B7D Q37141684-7FC4347E-7643-4ABE-A3E8-EB9F71B4A04D Q37170658-54A8F397-1180-48F8-9CA9-138CACC92857 Q37305731-3555C0DD-5586-4142-8F3D-8A02C6F402DB Q37455677-1D942123-D14F-4E86-B18E-E4E4E56FF0FC Q37536299-2E163A57-87D3-49BD-B5EB-AC9CED671293 Q37625797-7890E42B-E1CC-4E90-AA42-919A358F466A Q37696004-154964AC-15F4-46B9-B920-D16B926E0DDD Q37725826-45D4A354-6210-44AB-B43E-0DE5B4642FDE Q38118169-96E8F746-9845-4626-853A-F9EB3B35EA00 Q38161987-04324FDE-234D-44F1-85FE-4198B59564DA

P2860

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

http://www.wikidata.org/entity/Q35938554

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

@ast

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

@en

type

label

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

@ast

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

@en

prefLabel

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

@ast

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

@en

P1433

Q35938554-37ACA315-6F7E-42DF-B3AA-C6CECF2171E1

P1476

Q35938554-F231D220-2847-46B1-9C1F-A473EA7B5C48

P2093

Q35938554-1B6AE7AD-446C-41BD-B04C-F66D6943B349

Q35938554-1F56643B-30B5-4B6B-8099-227F851B98AB

Q35938554-2C19ABB5-C48A-4B5F-91A7-4FEC8040DAD9

Q35938554-362407F5-2912-442A-AF55-6E8008D52D5D

Q35938554-3A784A80-0640-43CC-9C74-C04DF6CC22D5

Q35938554-4B2B5E78-9FCF-48F9-B5FC-DA049F739D03

Q35938554-4F90D0B8-AF90-4160-ADE6-3470F8E4F1D5

Q35938554-5649EBAB-1F60-461B-9A0C-AFCC0FF4096B

Q35938554-5BFECDD8-9A5B-4E24-9A4E-54A98E8210FE

Q35938554-68A4B07A-5735-4165-A3DE-A4D63B166812

P2860

Q35938554-02B6049D-673B-4FD2-B0AA-7F4BE0C0D6E8

Q35938554-137B926F-56E9-4102-8302-0E8E4CBE382F

Q35938554-173856A0-60D0-412D-B414-CEC9C8F82CF3

Q35938554-2A5ECA16-0333-4ABA-BA0E-2919AAF027A4

Q35938554-2B28FE89-FA25-4E44-B0FD-598BA0898354

Q35938554-3079D97E-7972-43EE-9FA3-4980E66A82AC

Q35938554-36822389-919F-41D1-88A7-CF7868A3E8A6

Q35938554-3F4AB63F-D0B1-4399-A84B-1E872C5CD320

Q35938554-45F937BF-BCEF-4CEF-9FED-E09477DA7F95

Q35938554-4E52239A-B53C-4306-B333-7AB33F99BB4E

P304

Q35938554-5F2B9A47-2DCD-4C09-8DB4-C935339AF233

P31

Q35938554-D7C0AC66-05FE-47E6-ADE0-8653F5DAAEFB

P356

Q35938554-A048C350-48C9-4FE0-AE57-00C12D03D472

P407

Q35938554-DAFCAA4B-2C85-4F85-BA24-8CCB1DD4751C

P433

Q35938554-3802ED69-1AE7-49A5-BF1B-52300024CAEC

P478

Q35938554-8B6DD2BD-425C-4F3F-A95B-385A7AFAA412

P50

Q35938554-074C5797-96E7-4E03-AEA0-85B6C3D3A0C8

Q35938554-4D83D6DC-1698-4049-BCE2-0A11883078B3

P577

Q35938554-E3DC3182-B70D-4317-BCBC-ADC8E7A30401

P698

Q35938554-03514013-4910-4F1C-A77F-E9E9B3346156

P932

Q35938554-AAA5EEB7-5D69-450B-B713-D4334DFC8020

P356

WNL.0B013E318253D54B

P1433

P1476

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study

@en

P2093

A Colcher

http://www.w3.org/2001/XMLSchema#string

A Siderowf

http://www.w3.org/2001/XMLSchema#string

B Ford

http://www.w3.org/2001/XMLSchema#string

B Hiner

http://www.w3.org/2001/XMLSchema#string

B Ross

http://www.w3.org/2001/XMLSchema#string

C Comella

http://www.w3.org/2001/XMLSchema#string

C Tanner

http://www.w3.org/2001/XMLSchema#string

C Waters

http://www.w3.org/2001/XMLSchema#string

D Jennings

http://www.w3.org/2001/XMLSchema#string

D Ruiz

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

“Mini-mental state”

An Inventory for Measuring Depression

The Clinical Dementia Rating (CDR): current version and scoring rules

Current concepts in mild cognitive impairment.

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study.

Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

P304

1434-1440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E318253D54B

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22442429

http://www.w3.org/2001/XMLSchema#string

P932

3345785

http://www.w3.org/2001/XMLSchema#string